☆ 4.6 Article

Impact of the Double Mutants on Spike Protein of SARS-CoV-2 B.1.617 Lineage on the Human ACE2 Receptor Binding: A Structural Insight

VIRUSES-BASEL (2021)

Related references

Note: Only part of the references are listed.

Letter Public, Environmental & Occupational Health

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta variant of concern breakthrough infections: Are vaccines failing us?

Ali Nowroozi et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies

Meng Yuan et al.

Summary: Since the outbreak of COVID-19 pandemic, researchers from diverse biomedical and biological disciplines have collaborated to study the novel pandemic virus SARS-CoV-2. The focus has been on the antibody response to SARS-CoV-2, crucial for vaccine and therapeutic development. Most of the neutralizing antibodies for SARS-CoV-2 target the spike protein receptor binding domain (RBD).

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

Spike mutation D614G alters SARS-CoV-2 fitness

Jessica A. Plante et al.

Summary: The D614G substitution in the SARS-CoV-2 spike protein enhances viral replication and infectivity in human lung epithelial cells, primary airway tissues, and hamsters. This variant may increase transmission in the upper respiratory tract and doesn't seem to significantly reduce vaccine efficacy. Further research on therapeutic antibodies targeting the circulating G614 virus is recommended.

NATURE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion

Prabin Baral et al.

Summary: The surges of the more infectious Delta variant have intensified the health crisis, but current vaccines offer protection against it. However, the Delta variant can evade the immune system to some extent by reducing the receptivity of neutralizing antibodies.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2

Dong-Kyun Ryu et al.

Summary: CT-P59 demonstrates efficacy against Gamma and Delta variants in both cell and animal studies, indicating therapeutic potential for patients infected with these variants.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Jiwan Ge et al.

Summary: The authors compare the crystal structures and investigate the neutralization mechanisms of three neutralizing antibodies against SARS-CoV-2 and find that one antibody, P2C-1F11, closely mimics binding of receptor ACE2 and displays the most potent neutralizing activity in vitro, as well as conferring protection against SARS-CoV-2 infection in Ad5-hACE2-sensitized mice.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape

Qianqian Li et al.

Summary: The 501Y.V2 variants of SARS-CoV-2 with multiple mutations are rapidly spreading from South Africa to other countries, showing reduced susceptibility to neutralizing antibodies and potential compromise of monoclonal antibodies and vaccines. Enhanced infectivity in murine ACE2-overexpressing cells suggests the possibility of transmission to mice.

CELL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The antigenic anatomy of SARS-CoV-2 receptor binding domain

Wanwisa Dejnirattisai et al.

Summary: Antibodies play a crucial role in immune protection against SARS-CoV-2, with some being used as therapeutics. A study identified 377 human monoclonal antibodies, focusing on 80 that bind the virus spike, and found that most highly inhibitory antibodies can block the virus-receptor interaction. Novel binding modes of potent inhibitory antibodies were discovered, showing potential for prophylactic or therapeutic use in animal models.

CELL (2021)

Add to Collection

Review Microbiology

The variant gambit: COVID-19's next move

Jessica A. Plante et al.

Summary: Despite the development of vaccines, COVID-19 caused by SARS-CoV-2 continues to be a global concern due to the emergence of new variants, raising worries about increased spread and potential impacts on immunity.

CELL HOST & MICROBE (2021)

Add to Collection

Article Infectious Diseases

Novel SARS-CoV-2 variants: the pandemics within the pandemic

Erik Boehm et al.

Summary: Many new variants of SARS-CoV-2 have been identified as variants of concern/interest due to increased transmissibility, severity, immune escape, and reduced vaccine efficacy. These variants often share similar mutations, such as N501Y and E484K, which lead to partial immune escape, decreased vaccine efficacy, and potentially increased severity.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Review Biochemistry & Molecular Biology

SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity

Szu-Wei Huang et al.

Summary: The genetic diversity of SARS-CoV-2 and human populations plays a crucial role in determining the transmissibility and severity of COVID-19. The emergence of new variants with mutations in the spike protein could lead to immune escape and enhanced binding with ACE2, affecting virus entry into cells. Genetic variations in host proteins like ACE2 and TMPRSS2 may influence susceptibility to SARS-CoV-2 and impact the development of antiviral treatments and vaccines.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

News Item Multidisciplinary Sciences

CORONAVIRUS VARIANTS ARE SPREADING IN INDIA - WHAT SCIENTISTS KNOW SO FAR

Gayathri Vaidyanathan

NATURE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

Delphine Planas et al.

Summary: The ability of convalescent sera from individuals with coronavirus disease 2019 and those vaccinated with BNT162b2 to neutralize SARS-CoV-2 variants B1.1.7 and B.1.351 decreases, but increases after two vaccine doses. The study found that the B.1.1.7 and B.1.351 variants may have acquired partial resistance to neutralizing antibodies generated by natural infection or vaccination, particularly in individuals with low antibody levels. This suggests that the B.1.351 variant may pose a greater risk of infection in immunized individuals.

NATURE MEDICINE (2021)

Add to Collection

Article Cell Biology

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Bryan E. Jones et al.

Summary: LY-CoV555 is a novel neutralizing antibody derived from a convalescent patient with COVID-19, showing high affinity binding, potent inhibition of ACE2 binding, and strong neutralizing activity. This antibody has entered clinical trials and is being evaluated for various COVID-19 prevention and treatment indications.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Cell Biology

Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class

Micah Rapp et al.

Summary: Antibodies derived from the VH1-2 gene have been shown to be potent neutralizing antibodies against SARS-CoV-2, with three VH1-2-derived antibodies (2-15, 2-43, and H4) using VH1-2-encoded motifs to recognize the receptor-binding domain (RBD) of the virus spike protein. Despite genetic similarities, these antibodies are able to recognize both up and down conformations of the RBD, with some antibodies using elongated CDRH3s to interact with glycan N343 on a neighboring RBD. The VH1-2 antibody class utilizes modular genetic elements for modular recognition, with VH gene specifying RBD recognition and CDRH3 specifying quaternary interactions.

CELL REPORTS (2021)

Add to Collection

Article Microbiology

SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity

Chihiro Motozono et al.

Summary: Research has shown that certain mutations in SARS-CoV-2 variants can escape HLA-restricted cellular immunity, increase affinity for host cells, promote viral replication, and potentially affect the evolution of viral phenotypes.

CELL HOST & MICROBE (2021)

Add to Collection

Article Infectious Diseases

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel

Yaniv Lustig et al.

Summary: The study found that healthcare workers vaccinated with Comirnaty showed reduced neutralising titres against the Gamma, Beta, and Delta variants, but the remaining neutralisation capacity may still be protective.

EUROSURVEILLANCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas et al.

Summary: The SARS-CoV-2 B.1.617 Delta variant, first identified in India in 2020, has become dominant in some regions and is spreading to many countries. This variant shows resistance to certain monoclonal antibodies and antibodies in convalescent sera, as well as reduced neutralization by some COVID-19 vaccines. Administration of two doses of the vaccine is needed for a neutralizing response against the Delta variant.

NATURE (2021)

Add to Collection

Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Delta to dominate world

Adam Vaughan

NEW SCIENTIST (2021)

Add to Collection

Article Cell Biology

Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern

Hyeseon Cho et al.

Summary: Research isolated 216 monoclonal antibodies from patients with COVID-19, with three potent antibodies neutralizing the Alpha and Beta variants of SARS-CoV-2. Bispecific antibodies designed through distinct mechanisms showed high efficacy in inhibiting virus infection, with one exhibiting over 100-fold higher potency than a monoclonal antibody cocktail and protecting against disease in hamster models.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Virology

Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability

Jyoti Verma et al.

Summary: Research shows that the variants of the novel coronavirus increase its binding affinity with human cells, thereby enhancing the virus's infectivity and pathogenicity. Understanding the impact of these mutations can help in the development of vaccines and treatments.

VIROLOGY (2021)

Add to Collection

Review Virology

The Spike of Concern-The Novel Variants of SARS-CoV-2

Anna Winger et al.

Summary: The high sequence identity of the initial SARS-CoV-2 samples collected in Wuhan in December 2019 did not predict the emergence of novel variants in different regions around the world. The viral spike receptor has two areas of high mutagenic plasticity, with mutations mainly focusing on the N-terminal domain and receptor binding domain. The evolution of spike mutations, including the characteristic D614G mutation, continues to drive the development of new variants.

VIRUSES-BASEL (2021)

Add to Collection

News Item Medicine, General & Internal

Covid-19: Are high rates of B.1.617.2 linked to vaccine hesitancy?

Gareth Iacobucci

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Cell Biology

SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination

Markus Hoffmann et al.

Summary: The emergence of the B.1.617 variant in India may be responsible for the sharp increase in COVID-19 cases and deaths. B.1.617 shows increased efficiency in entering cells and evades antibody responses, contributing to its rapid spread.

CELL REPORTS (2021)

Add to Collection

Article Microbiology

SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India

Sarah Cherian et al.

Summary: Genomic epidemiology and whole genome sequencing were used to investigate the transmission and evolution of the SARS-CoV-2 virus during the global pandemic. The study identified new variants B.1.617.1 and B.1.617.2 in India, responsible for the second wave of COVID-19 in Maharashtra, with B.1.617.2 designated as a VOC delta and B.1.617.1 as a variant of interest kappa. Monitoring of these and emerging variants in India is crucial for public health.

MICROORGANISMS (2021)

Add to Collection

Article Infectious Diseases

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

Chih-Cheng Lai et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Add to Collection

Article Virology

Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS

Yushun Wan et al.

JOURNAL OF VIROLOGY (2020)

Add to Collection

Editorial Material Medicine, General & Internal

A novel coronavirus outbreak of global health concern

Chen Wang et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

First Case of 2019 Novel Coronavirus in the United States

Michelle L. Holshue et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Qun Li et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

Add to Collection

Article Immunology

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Wanbo Tai et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies

Chunyan Yi et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System Celebrating the 20th Anniversary of the Discovery of ACE2

Mahmoud Gheblawi et al.

CIRCULATION RESEARCH (2020)

Add to Collection

Article Medicine, General & Internal

SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate

Manuel Becerra-Flores et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2020)

Add to Collection

Article Multidisciplinary Sciences

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Jun Lan et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

Structural basis of receptor recognition by SARS-CoV-2

Jian Shang et al.

NATURE (2020)

Add to Collection

Review Chemistry, Multidisciplinary

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

Yuan Huang et al.

ACTA PHARMACOLOGICA SINICA (2020)

Add to Collection

Article Pharmacology & Pharmacy

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2

Wanbo Tai et al.

ANTIVIRAL RESEARCH (2020)

Add to Collection

Review Pharmacology & Pharmacy

Coronavirus membrane fusion mechanism offers a potential target for antiviral development

Tiffany Tang et al.

ANTIVIRAL RESEARCH (2020)

Add to Collection

Article Biochemistry & Molecular Biology

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Qianqian Li et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Bette Korber et al.

CELL (2020)

Add to Collection

Article Microbiology

Geographic and Genomic Distribution of SARS-CoV-2 Mutations

Daniele Mercatelli et al.

FRONTIERS IN MICROBIOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

Leonid Yurkovetskiy et al.

CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: Anin silicoinsight

Mohd Imran Khan et al.

PLOS ONE (2020)

Add to Collection

Review Virology

Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development

Subodh Kumar Samrat et al.

VIRUS RESEARCH (2020)

Add to Collection

Article Biology

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Yiska Weisblum et al.

ELIFE (2020)

Add to Collection

Article Pharmacology & Pharmacy

Discovering drugs to treat coronavirus disease 2019 (COVID-19)

Liying Dong et al.

DRUG DISCOVERIES AND THERAPEUTICS (2020)

Add to Collection

Article Thermodynamics

Energetic and exergetic performance assessment of the inclusion of phase change materials (PCM) in a solar distillation system

Mohamed S. Yousef et al.

ENERGY CONVERSION AND MANAGEMENT (2019)

Add to Collection

Editorial Material Biochemical Research Methods

POINTS OF SIGNIFICANCE Principal component analysis

Jake Lever et al.

NATURE METHODS (2017)

Add to Collection

Review Biochemistry & Molecular Biology

Mechanisms of viral mutation

Rafael Sanjuan et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2016)

Add to Collection

Review Virology

Structure, Function, and Evolution of Coronavirus Spike Proteins

Fang Li

ANNUAL REVIEW OF VIROLOGY, VOL 3 (2016)

Add to Collection

Article Physics, Mathematical

GMXPBSA 2.1: A GROMACS tool to perform MM/PBSA and computational alanine scanning

C. Paissoni et al.

COMPUTER PHYSICS COMMUNICATIONS (2014)

Add to Collection

Article Biochemical Research Methods

GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit

Sander Pronk et al.

BIOINFORMATICS (2013)

Add to Collection

Review Microbiology

Coronaviruses post-SARS: update on replication and pathogenesis

Stanley Perlman et al.

NATURE REVIEWS MICROBIOLOGY (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.